Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Intensive lipid intervention in the post-ENHANCE era.

O'Keefe JH, Bybee KA, Lavie CJ.

Mayo Clin Proc. 2008 Aug;83(8):867-9. doi: 10.4065/83.8.867. No abstract available.

PMID:
18674470
2.

First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.

[No authors listed]

Cardiovasc J Afr. 2008 Jan-Feb;19(1):60. No abstract available.

3.

[60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high].

[No authors listed]

MMW Fortschr Med. 2001 Nov 1;143(44):60. German. No abstract available.

PMID:
11732408
4.

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.

Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C.

PMID:
12646338
5.

[Ezetimib plus statin combination. A strong duo].

[No authors listed]

MMW Fortschr Med. 2002 Nov 28;144(48):53. German. No abstract available.

PMID:
12532547
6.

Therapy with statins is effective in some patients with homozygous familial hypercholesterolemia.

Tsimihodimos V, Miltiadous G, Elisaf M.

Atherosclerosis. 2000 Dec;153(2):527. No abstract available.

PMID:
11187858
7.

[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].

Karie S, Launay-Vacher V, Deray G, Isnard-Bagnis C.

Presse Med. 2006 Feb;35(2 Pt 1):219-29. Review. French.

PMID:
16493350
8.

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

McCormack T, Harvey P, Gaunt R, Allgar V, Chipperfield R, Robinson P; IN-PRACTICE study.

Int J Clin Pract. 2010 Jul;64(8):1052-61. doi: 10.1111/j.1742-1241.2010.02429.x. Epub 2010 May 12.

PMID:
20487050
9.

[High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].

Einecke D.

MMW Fortschr Med. 2006 Jun 15;148(24):4-5. German. No abstract available.

PMID:
16850796
10.

Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.

Reddy KJ, Singh M, Batsell RR, Bangit JR, Zaheer MS, John S, Varghese S, Molinella R.

J Clin Hypertens (Greenwich). 2009 Dec;11(12):766-8. doi: 10.1111/j.1559-4572.2009.00055.x.

11.

[The Saturn study].

Fineschi M, Gaspardone A.

G Ital Cardiol (Rome). 2012 Jul-Aug;13(7-8):469-73. doi: 10.1714/1114.12242. Italian. No abstract available.

PMID:
22781373
12.

[Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].

Sudhop T, von Bergmann K.

MMW Fortschr Med. 2003 May 22;145(21):19. German. No abstract available.

PMID:
12845862
13.

[Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].

[No authors listed]

MMW Fortschr Med. 2004 Oct 28;146(44):57. German. No abstract available.

PMID:
15566254
14.

Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia.

Wierzbicki AS, Lumb PJ, Chik G, Crook MA.

Am J Cardiol. 2001 Feb 1;87(3):338-40, A9.

PMID:
11165973
15.

Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.

Tomassini JE, Mazzone T, Goldberg RB, Guyton JR, Weinstock RS, Polis A, Jensen E, Tershakovec AM.

Diabetes Obes Metab. 2009 Sep;11(9):855-64. doi: 10.1111/j.1463-1326.2009.01061.x. Epub 2009 Jun 5.

PMID:
19508464
17.

Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.

Her AY, Kim JY, Kang SM, Choi D, Jang Y, Chung N, Manabe I, Lee SH.

J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):167-74. doi: 10.1177/1074248409357922. Epub 2010 Feb 10.

PMID:
20147603
18.

Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?

de Lorgeril M.

World Rev Nutr Diet. 2009;100:80-9. doi: 10.1159/000235714. Epub 2009 Aug 17. Review. No abstract available.

PMID:
19696530
19.

[How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].

[No authors listed]

MMW Fortschr Med. 2005 Nov 10;147(45):54. German. No abstract available.

PMID:
16320655
20.

Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.

King RI, Scott RS, Florkowski CM, Laurie AD, Reid N, George PM.

N Z Med J. 2010 Jul 30;123(1319):79-82. No abstract available.

PMID:
20717180
Items per page

Supplemental Content

Write to the Help Desk